🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Interesting article in press by Kolaitis et al! The 2015 Lung Allocation Score revisions improved outcomes and access to txplt in PAH patients but inequities persist. atsjournals.org/doi/epdf/10.11…

Les normes d’accessibilité canadiennes actuelles négligent les incapacités de mobilité invisibles (IMI). Mais, vous pouvez changer cela! Participez au projet IMI en remplissant leur sondage afin d'éliminer les obstacles. Projet IMI au ow.ly/eV9I50JaskE #UnicontrelHTP

The Bisserier Lab is hiring a lab technician. Experience in cell culture & molecular biology is preferred but not required. Know anyone who might be interested? Feel free to message me if you have any questions. Click here for more info: nymccareers-touro.icims.com/jobs/8962/labo… 3CPR Council The Pulmonary Vascular Research Institute

Merck announces positive Ph3 results for sotatercept in PAH ahead of schedule. A huge step forward for PAH care and the concept of disease modifying therapies. businesswire.com/news/home/2022…

1) Welcome to a new #accredited #tweetorial on #PulmonaryHypertension (#PH or #PAH) and its management, by expert author Jason Weatherald MD (@CalgaryPHdoc). Follow along and earn 0.5h CE/#CME #physicians #nurses #NPs #PAs #pharmacists! The Pulmonary Hypertension Association

📣📢 @ats_pc Early Career Professionals Highlight. This week we are highlighting Dr. William Oldham @wm_Oldham part of Brigham & Women's Pulmonary and Critical Care Harvard Medical School His research focuses on metabolic reprogramming in #PH and fibrosis using cell culture and animal models. 🫁

November is #PHAwarenessMonth! We will be highlighting PH events, webinars, and resources to raise awareness. Share your #PH stories! 🫁🫀

Who is excited for the 3CPR Council Cournand and Comroe Early Career Investigator Award Competition? 🙋‍♀️ 🫀🫁 #RV #PAH #AHA22

Another great session of the day for the 3CPR Council. Controversies in #RV dysfunction and management: A pro-con debate. #AHA22

Extremely proud of Lloyd—winner of the Cournand and Comroe Award at the AHA. Vascular Medicine Institute Lloyd Harvey, MD, PhD UPMC Heart and Vascular Institute 3CPR Council

Wonderful talk Sarah-Eve Lemay 3CPR Council

Packed session for the 3CPR Council Clinical Trials in #PH: Novel Biomarkers and Endpoints. #AHA22

Rapid abstract presentation from Suellen D`Arc Oliveira on Tlr4/py14-Caveolin-Mediated Endothelial C-iap2 expression during Schistosomiasis-Associated #PAH 3CPR Council ATS PC Assembly #EarlyCareer

Great lineup 3CPR Council sessions during the final day of #AHA22❗️AHAMeetings Sudarshan Rajagopal @DrSamanthaFn @MaryamS99704212 Sachin Agarwal Soban Umar, MD, PhD, FAHA, ATSF 🫁🫀 Lahouaria Hadri Francois Potus Fawaz Alenezi, MD Vineet Agrawal

If you missed some wonderful sessions, check out Scientific Sessions On-Demand! AHAMeetings #AHA22

Fantastic upcoming 3CPR Council webinar! Register at bit.ly/3lkHTYO to attend. Sudarshan Rajagopal Samantha Fernandez, MD Sachin Agarwal Soban Umar, MD, PhD, FAHA, ATSF 🫁🫀 Lahouaria Hadri Francois Potus Fawaz Alenezi, MD Vineet Agrawal AHA Science Stanford Wall Center ATS PC Assembly

We're thrilled to share our latest research in Circulation Journal, which demonstrates the important role of activin A and FSTL3 in predicting negative outcomes for PAH patients. Exciting news for patient care!

This important study from Christophe Guignabert Guignabert’s Team reveals that INHBA and FSTL3 are prognostic biomarkers of IPAH, lending more support for the concept that dysregulated activin axis signaling is a major driver and therapeutic target of PAH.

Intra-pocket ultrasound-guided axillary vein puncture vs cephalic vein cutdown for cardiac electronic device implantation: the ACCESS trial now in EHJ. doi.org/10.1093/eurhea… #CIED #vascular_access #PM #ICD #ultrasound

📢 Call for papers! Exploring the Role of Epigenetic Modifications in Pulmonary Vascular Disease Pathogenesis Edited by Sasha Prisco, MD, PhD Francois Potus Vineet Agrawal and Soban Umar, MD, PhD, FAHA, ATSF 🫁🫀 🗓️ 15 January 2024 Submit here➡️fro.ntiers.in/ycpX #epigenetics #pulmonaryvasculardiseases